
Inherited Retinal Diseases and more | Aspiring Retina Specialist @dukeeyecenter | PhD @moorfields | https://xitter.cf/t.co/10ZO18dbOF
Little Rock, AR
Joined March 2013
- Tweets234
- Following1.1K
- Followers1K
- Likes1.7K
Pinned Tweet
After 6 years of med school and 4 years of ophthalmology research, intern year, a PhD, 40+ papers, 400+ citations, 3 countries and 2 continents, it’s real.
Let me examine your eyes 👀
#ophthalmology #residency #medtwitter – at Little Rock, AR
Michalis Georgiou, MD, PhD retweeted
Ophthalmological manifestations in a cohort of Cowden
syndrome patients in a large tertiary healthcare system
What this study adds
· In a large U.S. tertiary system (Mass General Brigham), the observed CS prevalence was 1.28 per 100,000— somewhat higher than other prior population-based estimates.
· Among 77 confirmed CS patients, only 17 (22%) underwent ophthalmologic evaluation, and 4 patients (≈24% of those examined; 5% of the cohort) had ocular findings potentially related to CS. Visual acuity was mostly excellent and stable over a median ophthalmic follow-up of 4.5 years in this cohort
· Potential CS-related ocular findings included retinal hamartomas, an eyelid capillary hemangioma, a trichilemmoma, and a stable peripapillary hamartoma-like lesion/old CNVM. Only one patient had complete multimodal retinal imaging (OCT, FA, OCTA), underscoring limited ophthalmic documentation and the need for standardized eye screening in CS.
· Three of the four patients with ocular findings carried truncating PTEN variants, hinting at a possible genotype association that warrants larger, prospective studies.
· No distinct ocular phenotype emerged from the cohort plus literature synthesis, reinforcing calls for multicentre prospective work to define ocular risk and screening guidelines in CS. #Cowden @HMSeye #retina #PTEN
Michalis Georgiou, MD, PhD retweeted
Next-generation phenotyping of inherited retinal diseases: Eye2Gene (AI-driven algorithm). Better-than-expert accuracy for 63 common genetic causes.
@ucl @npontikos @GeoMichalis @MaximilianPfau3 @sktywagner @riksag @KonBalaskas #NIH
@NatMachIntell: brnw.ch/21wUfkJ
![Eye2Gene provides IRD-gene prediction given a retinal scan of one of three imaging modalities (FAF, IR or SD-OCT) for up to 63 gene classes. Images are initially resized to 256 by 256 pixels and rescaled to the range [0,1]. Each image modality-specific predictor block consists of an ensemble of five CoAtNet neural networks. The outputs are averaged to produce a final prediction output. The performance of Eye2Gene is evaluated on a held-out internal test dataset from MEH consisting of 28,174 images acquired from 524 patients over 9,291 patient visits since 2006.](https://pbs.twimg.com/media/GwI37RLXoAEmXLH.jpg?name=small&format=webp)
ALT Eye2Gene provides IRD-gene prediction given a retinal scan of one of three imaging modalities (FAF, IR or SD-OCT) for up to 63 gene classes. Images are initially resized to 256 by 256 pixels and rescaled to the range [0,1]. Each image modality-specific predictor block consists of an ensemble of five CoAtNet neural networks. The outputs are averaged to produce a final prediction output. The performance of Eye2Gene is evaluated on a held-out internal test dataset from MEH consisting of 28,174 images acquired from 524 patients over 9,291 patient visits since 2006.
Excited to see advancements in retinal research for X-linked retinitis pigmentosa. The community urges Johnson & Johnson to seek approval for its XLRP gene therapy, offering hope to patients. fightingblindness.org/news/r… @MichelMichaelid @UCL_Retina
Michalis Georgiou, MD, PhD retweeted
Happy #RareDiseaseDay2025! 👁️🧬
Let's make this another unbelievable year of discovery for rare eye diseases!
@MariyaMoosajee @MichelMichaelid @cm_stanton @neeru_vallabh @KarkStaphonsen @GeoMichalis @HeonJeon
#Ophthalmology #IRD #MedTwitter #ophthalmicgenetics #genetherapy
🗞️🚨I am incredibly grateful and humbled to be a part of this remarkable team @MichelMichaelid @UCL_Retina that delivered such a meaningful project. It has truly been life-changing and has had a positive impact on the children and their families.
lnkd.in/dfVn6v8T – at Durham, NC
Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study hubs.li/Q037K8wJ0
Pleasure to see our PDE6A study feature at @AAOjournal @MichelMichaelid – at Durham, NC
In patients with PDE6A-retinitis pigmentosa, despite the presence of cystoid macular edema, there was relative stability in macular parameters. @GeoMichalis @MichelMichaelid
ow.ly/3E9m50Toefe
New Publication @ARVOiovs 👁️
We expand on our previous work on CNGA3-Achromatopsia, longitudinally assessing the foveal cone mosaic preservation with adaptive optics. Kudos to Mohamed and the whole team! @UCL_Retina @AOIPLab @MichelMichaelid
iovs.arvojournals.org/articl… – at Durham, NC
Michalis Georgiou, MD, PhD retweeted
It is an honor to host Joseph Carroll, PhD,
Richard O. Shultz, MD & Ruth Works Professor in Ophthalmology from @MedicalCollege as the Dastgheib Pioneer Award in Ocular Innovation distinguished lecturer.
New in Ophthalmology Retina, our comprehensive analysis of PDE6A-retinopathy. @MichelMichaelid leading and an amazing team of co-authors.
This study details the natural history of PDE6A-retinopathy in one of the largest cohort to date.
sciencedirect.com/science/ar… – at Durham, NC
New @AJOphthalmology 🚨🧬👁️
Peer review data of one of the most promising trials in IRDs. Proud to be among an amazing group of collaborators! @MichelMichaelid @UCLeye @Moorfields
Safe and well-tolerated, and showed improvements in efficacy assessments. ajo.com/article/S0002-9394(2… – at London, England
Case report 🦄. Diagnosed RP in a patient with albinism, now confirmed for PDE6A-RP and TYR-albinism. Age-matched controls included. Out at AJO Case Reports.
#RetinitisPigmentosa #Albinism #Genetics 👁️@MichelMichaelid
Link:
sciencedirect.com/science/ar… – at Little Rock, AR
Ophthalmology Advocacy Day: Team Arkansas advocating for access to quality eye care, safety, research funding, and a sustainable profession. 👁️
@eyeadvocacy @aao_ophth #myf2024 #Advocacy #EyeCare #ResearchFunding #Arkansas
New Publication Alert!
Retinal structure in CSNB is stationary and no specific genotype - structure correlates were identified. VA appears to be relatively stable, with rare instances of progression. @MichelMichaelid @tacguimaraes
sciencedirect.com/science/ar… – at Little Rock, AR
Great pleasure to see our comprehensive review out! @MichelMichaelid – at Little Rock, AR
PRER article from @MichelMichaelid and collaborators who provide expert insight into genetics and imaging of photoreceptor degeneration #RetinaAwarenessMonth #retina #RP @MoorfieldsBRC
@UCLeye @Wills_Eye featureshttps://www.sciencedirect.com/science/article/pii/S1350946224000090
Michalis Georgiou, MD, PhD retweeted
PRER article from @MichelMichaelid and collaborators who provide expert insight into genetics and imaging of photoreceptor degeneration #RetinaAwarenessMonth #retina #RP @MoorfieldsBRC
@UCLeye @Wills_Eye featureshttps://www.sciencedirect.com/science/article/pii/S1350946224000090
We report the genetic findings, clinical spectrum and natural history of Best vitelliform macular dystrophy (BVMD) in a cohort of 222 children and adults. @MichelMichaelid @Moorfields @UCL_Retina Kudos to Yannik Laich and an amazing group of co-authors! – at Little Rock, AR
Best vitelliform macular dystrophy is a slowly progressive disease and phenotype- genotype correlations can be used for more accurate prognostication and counseling in this phenotypically diverse disorder. ow.ly/RAOk50QxSFA
Fresh off the press @AJOphthalmology our comprehensive analysis of PDE6B-retinopathy. @MichelMichaelid , Shaima Hashem and an amazing team of co-authors.
This study details the natural history of PDE6B-retinopathy in one of the largest cohort to date.
ajo.com/article/S0002-9394(2… – at Little Rock, AR
Fresh off the press at @AJOphthalmology our comperative analysis study for cataract surgical outcomes in eye with retinitis pigmentosa. @ShakarchiAhmed @MichelMichaelid
*Early Surgery
*Safe Surgery
*Good Outcomes
*More CME and PCO
ajo.com/article/S0002-9394(2… – at Little Rock, AR
New in "Progress in Retina and Eye Research" - a comprehensive review on the incredible work of our IRD community over the past two decades. A milestone mid-career review for @MichelMichaelid (>350 publications) and an early career highlight for me (>70) sciencedirect.com/science/ar… – at Little Rock, AR
New publication @AAOjournal We analyse @MichelMichaelid @UCL_Retina @Moorfields @UCLeye, the genetic findings, clinical spectrum and natural history of Best vitelliform macular dystrophy (BVMD) in a cohort of 222 children and adults.
Report 1: aaojournal.org/article/S0161… – at Little Rock, AR
























